InventionMed S.A. (WSE:INM)
Poland
· Delayed Price · Currency is PLN 0.116
0.00 (0.00%)
At close: Dec 5, 2025
InventionMed Revenue
InventionMed had revenue of 390.80K PLN in the quarter ending September 30, 2025, with 237.59% growth. This brings the company's revenue in the last twelve months to 2.28M, up 1,305.86% year-over-year. In the year 2024, InventionMed had annual revenue of 277.76K with 45,810.74% growth.
Revenue (ttm)
2.28M
Revenue Growth
+1,305.86%
P/S Ratio
10.26
Revenue / Employee
570.50K
Employees
5
Market Cap
23.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |